Free Trial

10x Genomics (TXG) News Today

10x Genomics logo
$8.31 +0.29 (+3.62%)
As of 04:00 PM Eastern
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Boosted by Barclays PLC
Barclays PLC lifted its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 31.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 790,957 shares of the company's stock after buying an additional 188,421 shares during the pe
10x Genomics, Inc. stock logo
Renaissance Technologies LLC Acquires Shares of 386,955 10x Genomics, Inc. (NASDAQ:TXG)
Renaissance Technologies LLC bought a new position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 386,955 shares of the company's sto
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. cut its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 16.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 296,902 shares of the company's stock after selling 58,586 shares
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Shares Gap Down - Here's Why
10x Genomics (NASDAQ:TXG) Shares Gap Down - What's Next?
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Holdings Boosted by Capital Fund Management S.A.
Capital Fund Management S.A. raised its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 36.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 304,832 shares of the company's sto
10x Genomics, Inc. stock logo
Fmr LLC Raises Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Fmr LLC increased its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 0.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,454,434 shares of the company's stock after buying an add
10x Genomics price target lowered to $12 from $16 at BofA
10x Genomics, Inc. stock logo
Norges Bank Acquires New Position in 10x Genomics, Inc. (NASDAQ:TXG)
Norges Bank bought a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 91,579 shares of the company's stock, valued at approximately
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Analysts
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) has been given an average recommendation of "Hold" by the seventeen research firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, nine have issued a hold ratin
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Shares Up 7% - Here's What Happened
10x Genomics (NASDAQ:TXG) Shares Up 7% - Time to Buy?
10x Genomics, Inc. stock logo
National Bank of Canada FI Purchases New Position in 10x Genomics, Inc. (NASDAQ:TXG)
National Bank of Canada FI acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 105,700 shares of the company's stock, valued at approx
Barclays Reaffirms Their Buy Rating on 10x Genomics (TXG)
10x Genomics price target lowered to $12 from $15 at Barclays
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings
Weiss Ratings reaffirmed a "sell (e+)" rating on shares of 10x Genomics in a research report on Tuesday.
10x Genomics, Inc. stock logo
ExodusPoint Capital Management LP Sells 366,528 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
ExodusPoint Capital Management LP cut its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 66.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 188,430 shares of the c
10x Genomics, Inc. stock logo
Vanguard Group Inc. Has $157.01 Million Stake in 10x Genomics, Inc. (NASDAQ:TXG)
Vanguard Group Inc. cut its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,933,549 shares of the company's stock after selling 39,381 shares du
10x Genomics, Inc. stock logo
Cinctive Capital Management LP Sells 138,106 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Cinctive Capital Management LP trimmed its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 84.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,479 shares of the company's stock after selling
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Trexquant Investment LP
Trexquant Investment LP raised its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 196.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 594,611 shares of the company's stock after purchasi
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Sets New 12-Month Low - What's Next?
10x Genomics (NASDAQ:TXG) Hits New 52-Week Low - Should You Sell?
10x Genomics, Inc. stock logo
IQ EQ FUND MANAGEMENT IRELAND Ltd Increases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 160.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,787 shares of the company's stock after purchasing an addition
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Stock Price Down 5.7% - Time to Sell?
10x Genomics (NASDAQ:TXG) Shares Down 5.7% - Here's Why
10x Genomics, Inc. stock logo
Quantbot Technologies LP Invests $1.03 Million in 10x Genomics, Inc. (NASDAQ:TXG)
Quantbot Technologies LP acquired a new position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 71,429 shares of the company's stock, valued at appro
10x Genomics, Inc. stock logo
Charles Schwab Investment Management Inc. Trims Position in 10x Genomics, Inc. (NASDAQ:TXG)
Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 17.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 539,666 shares of the company's stock after selling 11
10x Genomics, Inc. stock logo
10x Genomics' (TXG) Sell (E+) Rating Reiterated at Weiss Ratings
Weiss Ratings restated a "sell (e+)" rating on shares of 10x Genomics in a report on Saturday.
10x Genomics, Inc. stock logo
Amundi Reduces Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Amundi reduced its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 98.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,988 shares of the company's stock after selling 98,904 shares
10x Genomics, Inc. stock logo
Primecap Management Co. CA Lowers Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)
Primecap Management Co. CA trimmed its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 56.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 127,600 shares of the company's stock
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Short Interest Up 21.6% in February
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 13,770,000 shares, an increase of 21.6% from the February 13th total of 11,320,000 shares. Currently, 12.6% of the shares of the company are sold short. Based on an average trading volume of 2,480,000 shares, the short-interest ratio is presently 5.6 days.
10x Genomics, Inc. stock logo
Bank of New York Mellon Corp Reduces Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Bank of New York Mellon Corp lessened its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 13.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 290,031 shares of the company's stock after selling 45,337 shar
10x Genomics, Inc. stock logo
Nikko Asset Management Americas Inc. Reduces Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)
Nikko Asset Management Americas Inc. lessened its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 10.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,713,484 shares of the company's stock after sellin
10x Genomics, Inc. stock logo
Counterpoint Mutual Funds LLC Invests $742,000 in 10x Genomics, Inc. (NASDAQ:TXG)
Counterpoint Mutual Funds LLC acquired a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 51,658 shares of the company's stock, valued at approximately $742,
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Receives Average Rating of "Hold" from Analysts
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) has been assigned an average rating of "Hold" from the seventeen brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and seve
10x Genomics, Inc. stock logo
Wealthfront Advisers LLC Takes Position in 10x Genomics, Inc. (NASDAQ:TXG)
Wealthfront Advisers LLC acquired a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 332,210 shares of the co
2 Reasons to Sell TXG and 1 Stock to Buy Instead
10x Genomics, Inc. stock logo
Edgestream Partners L.P. Invests $2.74 Million in 10x Genomics, Inc. (NASDAQ:TXG)
Edgestream Partners L.P. bought a new position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 190,714 shares of the company's stock, valued at approximately $2,739,000. Edgestream Partn
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Trading Up 4.9% - Time to Buy?
10x Genomics (NASDAQ:TXG) Trading Up 4.9% - Still a Buy?
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Price Target Lowered to $15.00 at Citigroup
Citigroup decreased their target price on shares of 10x Genomics from $20.00 to $15.00 and set a "buy" rating for the company in a report on Tuesday.
10x Genomics price target lowered to $15 from $20 at Citi
10x Genomics, Inc. stock logo
Short Interest in 10x Genomics, Inc. (NASDAQ:TXG) Expands By 34.4%
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) was the target of a significant increase in short interest during the month of February. As of February 15th, there was short interest totalling 11,320,000 shares, an increase of 34.4% from the January 31st total of 8,420,000 shares. Based on an average trading volume of 2,280,000 shares, the short-interest ratio is presently 5.0 days.
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Hits New 52-Week Low - Time to Sell?
10x Genomics (NASDAQ:TXG) Sets New 1-Year Low - Should You Sell?
10x Genomics, Inc. stock logo
SVB Wealth LLC Acquires Shares of 522,609 10x Genomics, Inc. (NASDAQ:TXG)
SVB Wealth LLC acquired a new stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 522,609 shares of the company's stock, valued at approximately $7,505,000. SVB Wealth
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Insider Benjamin J. Hindson Sells 4,573 Shares
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) insider Benjamin J. Hindson sold 4,573 shares of the business's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $11.07, for a total transaction of $50,623.11. Following the completion of the transaction, the insider now owns 335,324 shares in the company, valued at approximately $3,712,036.68. This trade represents a 1.35 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
10x Genomics, Inc. stock logo
Serge Saxonov Sells 5,092 Shares of 10x Genomics, Inc. (NASDAQ:TXG) Stock
10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) CEO Serge Saxonov sold 5,092 shares of the firm's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $11.07, for a total transaction of $56,368.44. Following the completion of the sale, the chief executive officer now owns 879,482 shares of the company's stock, valued at $9,735,865.74. This trade represents a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Get 10x Genomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.

TXG Media Mentions By Week

TXG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TXG
News Sentiment

1.60

0.72

Average
Medical
News Sentiment

TXG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TXG Articles
This Week

4

6

TXG Articles
Average Week

Get 10x Genomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TXG) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners